Tema ETFs
CADL icon

Tema ETFs’s Candel Therapeutics CADL Stock Holding History

Tema ETFs’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$920K Buy
+88,097
New +$976K 0.03% 304

Other funds holding CADL

Tanager Wealth Management
Tanager Wealth Management Goring On Thames, United Kingdom $1.2B AUM 12% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Tema ETFs's CADL Position: Q3 2026 in Review

Tema ETFs opened a new position in Candel Therapeutics (CADL) in Q3 2026: 88,097 shares worth $920K. The stake represents 0.03% of the portfolio and ranks #304 among its holdings.

6 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

  • Tema ETFs held 88,097 shares of Candel Therapeutics worth $920K as of Q3 2026.
  • Candel Therapeutics was a new Tema ETFs position in Q3 2026.
  • Candel Therapeutics made up 0.03% of Tema ETFs's portfolio in Q3 2026, its #304 holding.
  • 6 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.